0
0

A bill to establish or continue a multidisciplinary research program to advance the discovery and preclinical development of medical products for priority virus families and other viral pathogens with a significant potential to cause a pandemic, and for other purposes.

12/30/2022, 4:04 AM

Congressional Summary of S 3489

This bill directs the National Institutes of Health (NIH) to support research on medical products for virus families and viral pathogens with pandemic potential.

Specifically, the NIH must establish or continue a multidisciplinary program for supporting research centers to advance the discovery and development of medical products to prevent, treat, and diagnose such viruses.

Current Status of Bill S 3489

Bill S 3489 is currently in the status of Bill Introduced since January 12, 2022. Bill S 3489 was introduced during Congress 117 and was introduced to the Senate on January 12, 2022.  Bill S 3489's most recent activity was Read twice and referred to the Committee on Health, Education, Labor, and Pensions. as of January 12, 2022

Bipartisan Support of Bill S 3489

Total Number of Sponsors
1
Democrat Sponsors
0
Republican Sponsors
1
Unaffiliated Sponsors
0
Total Number of Cosponsors
1
Democrat Cosponsors
1
Republican Cosponsors
0
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill S 3489

Primary Policy Focus

Health

Potential Impact Areas

- Chemical and biological weapons
- Department of Health and Human Services
- Drug therapy
- Emergency medical services and trauma care
- Hazardous wastes and toxic substances
- Health programs administration and funding
- Health promotion and preventive care
- Health technology, devices, supplies
- Home and outpatient care
- Infectious and parasitic diseases
- Medical research
- Medical tests and diagnostic methods
- National Institutes of Health (NIH)
- Nuclear weapons
- Product development and innovation
- Research administration and funding
- Research and development
- Scientific communication

Alternate Title(s) of Bill S 3489

A bill to establish or continue a multidisciplinary research program to advance the discovery and preclinical development of medical products for priority virus families and other viral pathogens with a significant potential to cause a pandemic, and for other purposes.
A bill to establish or continue a multidisciplinary research program to advance the discovery and preclinical development of medical products for priority virus families and other viral pathogens with a significant potential to cause a pandemic, and for other purposes.

Comments